The store will not work correctly when cookies are disabled.
8-methoxy-2-methyl-5H-pyrido[4,3-b]indol-2-ium iodide
ID: ALA4857977
PubChem CID: 164611936
Max Phase: Preclinical
Molecular Formula: C13H13IN2O
Molecular Weight: 213.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc2[nH]c3cc[n+](C)cc3c2c1.[I-]
Standard InChI: InChI=1S/C13H12N2O.HI/c1-15-6-5-13-11(8-15)10-7-9(16-2)3-4-12(10)14-13;/h3-8H,1-2H3;1H
Standard InChI Key: BFNZZJUMQUNABL-UHFFFAOYSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
44.4172 -16.2200 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
41.6917 -16.9205 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.0259 -16.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2805 -15.6638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7360 -15.0573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9369 -15.2258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6851 -16.0062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2313 -16.6094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0922 -15.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3457 -16.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1409 -16.6038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6834 -15.9970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4253 -15.2215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.6307 -15.0591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9675 -14.6101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3899 -14.6186 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.6423 -13.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 10 1 0
9 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
6 16 1 0
16 17 1 0
M CHG 2 1 -1 13 1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 213.26 | Molecular Weight (Monoisotopic): 213.1022 | AlogP: 2.15 | #Rotatable Bonds: 1 |
Polar Surface Area: 28.90 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.00 | CX Basic pKa: ┄ | CX LogP: -2.23 | CX LogD: -2.23 |
Aromatic Rings: 3 | Heavy Atoms: 16 | QED Weighted: 0.62 | Np Likeness Score: 0.32 |
References
1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T.. (2021) Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors., 46 [PMID:34391122] [10.1016/j.bmc.2021.116355] |